Hepatitis C (Hep C) infection is increasing in Arkansas, according to new research published in the May 2015 issue of the Journal of the Arkansas Medical Society. The research, conducted by physicians and epidemiologists from the Arkansas Department of Health and University of Arkansas for Medical Sciences, showed that Hep C-related hospitalizations increased from 2,837 in 2004, to 4,141 in 2012. In addition, Hep C is now a leading cause or contributing factor in more deaths than HIV; the most recent data available suggests Hep C-related deaths occur at nearly twice the rate of HIV-related deaths.
Dr. Naveen Patil with the Arkansas Department of Health says, "We believe that in Arkansas there may be about 30,000 people who might be chronically infected and a majority of them may not be knowing about it. People who are infected at that time. It usually takes decades for people to manifest the disease of chronic infection, maybe 30-40-50 years. So we are seeing an increased burden of that disease with all it's chronic manifestations right now."
As a result, the Arkansas Department of Health (ADH) is encouraging all individuals born between 1945 and 1965, or anyone who is at risk for infection, get tested for Hepatitis C at least once. Testing is available at all 94 county health units, and individuals may also ask their primary care doctor about getting tested.
Read more...
Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.
Alan Franciscus
Editor-in-Chief
HCV Advocate
Showing posts with label Arkansas. Show all posts
Showing posts with label Arkansas. Show all posts
Thursday, May 7, 2015
Wednesday, April 22, 2015
Arkansas: State panel OKs more hepatitis-C drug buys
More teachers and state employees with hepatitis-C will be eligible for treatment with expensive drugs under changes adopted by a state board on Tuesday.
The changes approved by the State and Public School Life and Health Insurance Board broadened criteria for the treatment that the board set just over a month ago for coverage of the drugs, which can cost more than $86,000 for a 12-week course of treatment.
The changes will also allow most patients who meet the criteria to take a drug regimen that does not involve injections of interferon, which can cause flulike side effects.
Subscribe to:
Posts (Atom)